longterm 1
safety 1
efficacy 1
dalfampridine 2
walking 1
impairment 1
patients 1
multiple 4
sclerosis 4
results 1
openlabel 1
extensions 1
phase 2
clinical 1
trials 1
trial 3
extended 1
release 1
oral 2
sustainedrelease 2
fampridine 2
randomised 1
doubleblind 1
controlled 1
dose 1
comparison 1
